Bing Xue - Jan 16, 2024 Form 4 Insider Report for ALPHA & OMEGA SEMICONDUCTOR Ltd (AOSL)

Signature
/s/ Yanbing Hong, attoryney-in-fact for Bing Xue
Stock symbol
AOSL
Transactions as of
Jan 16, 2024
Transactions value $
-$35,081
Form type
4
Date filed
1/16/2024, 08:38 PM
Previous filing
Jan 5, 2024
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AOSL Common Share Sale -$35.1K -1.34K -0.91% $26.16 146K Jan 16, 2024 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2023.
F2 The price reported in Column 4 is the exact price at which all shares were sold.
F3 Includes 8,707 unvested shares subject to the PSU granted on March 15, 2022 which are subject to vesting upon satisfaction of service-based vesting conditions by the Reporting Person.
F4 Includes an aggregate of 43,750 shares subject to Restricted Share Unit awards (RSU) granted on March 16, 2020, March 15, 2021, August 12, 2021, March 15, 2022, and March 15, 2023 which will be issued as such units vest in accordance with their terms, and excludes 18,390 unvested common shares subject to the PSU granted on March 15, 2023, which may become vested upon achievement of certain corporate performance goals in the future.